BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoo JH. What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021. J Korean Med Sci 2021;36:e54. [PMID: 33559409 DOI: 10.3346/jkms.2021.36.e54] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Ebrahim F, Tabal S, Lamami Y, Alhudiri IM, El Meshri SE, Al Dwigen S, Arfa R, Alboeshi A, Alemam HA, Abuhtna F, Altrhouni R, Milad MB, Elgriw NA, Ruaua MA, Abusrewil Z, Harroush W, Jallul M, Ali FS, Eltaib F, Elzagheid A. Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 or Post-Vaccination in Libyan Population: Comparison of Four Vaccines. Vaccines (Basel) 2022;10. [PMID: 36560411 DOI: 10.3390/vaccines10122002] [Reference Citation Analysis]
2 Gutiérrez LJ, Tosso RD, Zarycz MNC, Enriz RD, Baldoni HA. Epitopes mapped onto SARS-CoV-2 receptor-binding motif by five distinct human neutralising antibodies. Molecular Simulation. [DOI: 10.1080/08927022.2022.2111421] [Reference Citation Analysis]
3 Mubarak A, Almutairi S, Al-Dhabbah AD, Aldabas SY, Bhat R, Alqoufail MM, Abdel-Maksoud MA, Almanaa TN, Farrag MA, Alturaiki W. Durability of SARS-CoV-2 Specific IgG Antibody Responses Following Two Doses of Match and Mixed COVID-19 Vaccines Regimens in Saudi Population. Infect Drug Resist 2022;15:3791-800. [PMID: 35875613 DOI: 10.2147/IDR.S369769] [Reference Citation Analysis]
4 Kolosova EA, Shaprova ON, Shanshin DV, Nesmeyanova VS, Merkuleva IA, Belenkaya SV, Isaeva AA, Nikitin AO, Volosnikova EA, Nikulina YA, Nikonorova MA, Shcherbakov DN, Elchaninova SA. Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4–13 Months after COVID-19. JCM 2022;11:4053. [DOI: 10.3390/jcm11144053] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Rajpal VR, Sharma S, Sehgal D, Singh A, Kumar A, Vaishnavi S, Tiwari M, Bhalla H, Goel S, Raina SN. A comprehensive account of SARS-CoV-2 genome structure, incurred mutations, lineages and COVID-19 vaccination program. Future Virol 2022. [PMID: 35747328 DOI: 10.2217/fvl-2021-0277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ebrahim F, Tabal S, Lamami Y, Alhudiri IM, El Meshri SE, Al Dwigen SM, Arfa R, Alboeshi A, Alemam HA, Abuhtna F, Altrhouni R, Milad MB, Elgriw NA, Ruaua MA, Abusrewil Z, Harroush W, Jallul M, Ali FS, Eltaib F, Elzaghied A. Immunity post-COVID-19 recovery boosts the antibody immune response to SARS-CoV-2 vaccination.. [DOI: 10.1101/2022.02.18.22271130] [Reference Citation Analysis]
7 Kantarcioglu B, Iqbal O, Lewis J, Carter CA, Singh M, Lievano F, Ligocki M, Jeske W, Adiguzel C, Gerotziafas GT, Fareed J. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations. Clin Appl Thromb Hemost 2022;28:10760296211056648. [PMID: 35167393 DOI: 10.1177/10760296211056648] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
8 Hong SM, Park YW, Choi EJ. Steroid injections in pain management: influence on coronavirus disease 2019 vaccines. Korean J Pain 2022;35:14-21. [PMID: 34966008 DOI: 10.3344/kjp.2022.35.1.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Peng XL, Cheng JS, Gong HL, Yuan MD, Zhao XH, Li Z, Wei DX. Advances in the design and development of SARS-CoV-2 vaccines. Mil Med Res 2021;8:67. [PMID: 34911569 DOI: 10.1186/s40779-021-00360-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
10 Choi UY, Jung SE, Kim MS, Oh HS, Kwon YM, Lee J, Choi JH. Analysis of a COVID-19 Prescreening Process in an Outpatient Clinic at a University Hospital during the COVID-19 Pandemic. J Korean Med Sci 2021;36:e295. [PMID: 34725979 DOI: 10.3346/jkms.2021.36.e295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Chavda VP, Pandya R, Apostolopoulos V. DNA vaccines for SARS-CoV-2: toward third-generation vaccination era. Expert Rev Vaccines 2021;:1-12. [PMID: 34582298 DOI: 10.1080/14760584.2021.1987223] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
12 Altawalah H. Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination. Vaccines (Basel) 2021;9:910. [PMID: 34452035 DOI: 10.3390/vaccines9080910] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
13 Choi JK, Kim S, Kim SR, Jin JY, Choi SW, Kim H, Yoo JH, Park IS, Kim SR. Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in Korea. J Korean Med Sci 2021;36:e223. [PMID: 34402235 DOI: 10.3346/jkms.2021.36.e223] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
14 Abdulla ZA, Al-Bashir SM, Al-Salih NS, Aldamen AA, Abdulazeez MZ. A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development. Pathogens 2021;10:788. [PMID: 34206507 DOI: 10.3390/pathogens10070788] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
15 Damodharan K, Arumugam GS, Ganesan S, Doble M, Thennarasu S. A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2. RSC Adv 2021;11:20006-35. [PMID: 35479882 DOI: 10.1039/d0ra09668g] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Tian CY. China is facing serious experimental monkey shortage during the COVID-19 lockdown. J Med Primatol 2021;50:225-7. [PMID: 34036592 DOI: 10.1111/jmp.12528] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Loo KY, Letchumanan V, Ser HL, Teoh SL, Law JW, Tan LT, Ab Mutalib NS, Chan KG, Lee LH. COVID-19: Insights into Potential Vaccines. Microorganisms 2021;9:605. [PMID: 33804162 DOI: 10.3390/microorganisms9030605] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]